These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 21782458)

  • 1. Structural basis of substrate methylation and inhibition of SMYD2.
    Ferguson AD; Larsen NA; Howard T; Pollard H; Green I; Grande C; Cheung T; Garcia-Arenas R; Cowen S; Wu J; Godin R; Chen H; Keen N
    Structure; 2011 Sep; 19(9):1262-73. PubMed ID: 21782458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of human lysine methyltransferase Smyd2 reveals insights into the substrate divergence in Smyd proteins.
    Xu S; Zhong C; Zhang T; Ding J
    J Mol Cell Biol; 2011 Oct; 3(5):293-300. PubMed ID: 21724641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical characterization of human SET and MYND domain-containing protein 2 methyltransferase.
    Wu J; Cheung T; Grande C; Ferguson AD; Zhu X; Theriault K; Code E; Birr C; Keen N; Chen H
    Biochemistry; 2011 Jul; 50(29):6488-97. PubMed ID: 21678921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis, and Biological Activity of Substrate Competitive SMYD2 Inhibitors.
    Cowen SD; Russell D; Dakin LA; Chen H; Larsen NA; Godin R; Throner S; Zheng X; Molina A; Wu J; Cheung T; Howard T; Garcia-Arenas R; Keen N; Pendleton CS; Pietenpol JA; Ferguson AD
    J Med Chem; 2016 Dec; 59(24):11079-11097. PubMed ID: 28002961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and catalytic mechanism of the human histone methyltransferase SET7/9.
    Xiao B; Jing C; Wilson JR; Walker PA; Vasisht N; Kelly G; Howell S; Taylor IA; Blackburn GM; Gamblin SJ
    Nature; 2003 Feb; 421(6923):652-6. PubMed ID: 12540855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of human SMYD2 protein reveals the basis of p53 tumor suppressor methylation.
    Wang L; Li L; Zhang H; Luo X; Dai J; Zhou S; Gu J; Zhu J; Atadja P; Lu C; Li E; Zhao K
    J Biol Chem; 2011 Nov; 286(44):38725-38737. PubMed ID: 21880715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2.
    Nguyen H; Allali-Hassani A; Antonysamy S; Chang S; Chen LH; Curtis C; Emtage S; Fan L; Gheyi T; Li F; Liu S; Martin JR; Mendel D; Olsen JB; Pelletier L; Shatseva T; Wu S; Zhang FF; Arrowsmith CH; Brown PJ; Campbell RM; Garcia BA; Barsyte-Lovejoy D; Mader M; Vedadi M
    J Biol Chem; 2015 May; 290(22):13641-53. PubMed ID: 25825497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights into estrogen receptor α methylation by histone methyltransferase SMYD2, a cellular event implicated in estrogen signaling regulation.
    Jiang Y; Trescott L; Holcomb J; Zhang X; Brunzelle J; Sirinupong N; Shi X; Yang Z
    J Mol Biol; 2014 Oct; 426(20):3413-25. PubMed ID: 24594358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of p53 activity by Smyd2-mediated methylation.
    Huang J; Perez-Burgos L; Placek BJ; Sengupta R; Richter M; Dorsey JA; Kubicek S; Opravil S; Jenuwein T; Berger SL
    Nature; 2006 Nov; 444(7119):629-32. PubMed ID: 17108971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for the methylation site specificity of SET7/9.
    Couture JF; Collazo E; Hauk G; Trievel RC
    Nat Struct Mol Biol; 2006 Feb; 13(2):140-6. PubMed ID: 16415881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analyses of the SMYD family interactomes identify HSP90 as a novel target for SMYD2.
    Abu-Farha M; Lanouette S; Elisma F; Tremblay V; Butson J; Figeys D; Couture JF
    J Mol Cell Biol; 2011 Oct; 3(5):301-8. PubMed ID: 22028380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic properties and kinetic mechanism of human recombinant Lys-9 histone H3 methyltransferase SUV39H1: participation of the chromodomain in enzymatic catalysis.
    Chin HG; Patnaik D; Estève PO; Jacobsen SE; Pradhan S
    Biochemistry; 2006 Mar; 45(10):3272-84. PubMed ID: 16519522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smyd2 conformational changes in response to p53 binding: role of the C-terminal domain.
    Chandramouli B; Melino G; Chillemi G
    Mol Oncol; 2019 Jun; 13(6):1450-1461. PubMed ID: 31069954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of p53 activity through lysine methylation.
    Chuikov S; Kurash JK; Wilson JR; Xiao B; Justin N; Ivanov GS; McKinney K; Tempst P; Prives C; Gamblin SJ; Barlev NA; Reinberg D
    Nature; 2004 Nov; 432(7015):353-60. PubMed ID: 15525938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression.
    Li LX; Zhou JX; Calvet JP; Godwin AK; Jensen RA; Li X
    Cell Death Dis; 2018 Feb; 9(3):326. PubMed ID: 29487338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of product specificity of AdoMet methylation catalyzed by lysine methyltransferases: transcriptional factor p53 methylation by histone lysine methyltransferase SET7/9.
    Zhang X; Bruice TC
    Biochemistry; 2008 Mar; 47(9):2743-8. PubMed ID: 18260647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational Dynamics of Lysine Methyltransferase Smyd2. Insights into the Different Substrate Crevice Characteristics of Smyd2 and Smyd3.
    Chandramouli B; Chillemi G
    J Chem Inf Model; 2016 Dec; 56(12):2467-2475. PubMed ID: 27959541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Profiling of the Activity of Protein Lysine Methyltransferase SMYD2 Using SILAC-Based Proteomics.
    Olsen JB; Cao XJ; Han B; Chen LH; Horvath A; Richardson TI; Campbell RM; Garcia BA; Nguyen H
    Mol Cell Proteomics; 2016 Mar; 15(3):892-905. PubMed ID: 26750096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural insights of the specificity and catalysis of a viral histone H3 lysine 27 methyltransferase.
    Qian C; Wang X; Manzur K; Sachchidanand ; Farooq A; Zeng L; Wang R; Zhou MM
    J Mol Biol; 2006 May; 359(1):86-96. PubMed ID: 16603186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2.
    Eggert E; Hillig RC; Koehr S; Stöckigt D; Weiske J; Barak N; Mowat J; Brumby T; Christ CD; Ter Laak A; Lang T; Fernandez-Montalvan AE; Badock V; Weinmann H; Hartung IV; Barsyte-Lovejoy D; Szewczyk M; Kennedy S; Li F; Vedadi M; Brown PJ; Santhakumar V; Arrowsmith CH; Stellfeld T; Stresemann C
    J Med Chem; 2016 May; 59(10):4578-600. PubMed ID: 27075367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.